Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like ...

I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and ...

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance ...

Panelists discuss City of Hope’s collaborative partnership with community physicians, emphasizing expert evaluation at specialized centers while enabling ongoing treatment closer to home for ...

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T cell engagers, ...

Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple myeloma, while expressing optimism about emerging therapies like CAR T cells ...

Writing and reading help me stay grounded and find meaning while living with chronic cancer, balancing health, family and ...

In an interview with CURE, medical oncologist Dr. Ioana Bonta explains why lung cancer is not just a ‘smoker’s disease.’ ...

It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect ...

The FDA has approved the Oncomine Dx Target Test to identify patients with HER2-mutant non-small cell lung cancer who are ...

Ashley Dieks and Dr. Saad Z. Usmani discussed how bicycling may help patients cope with the emotional and physical challenges ...